Description
GENETIC&ESTOTERIC TESTING
Base award description: IGF::OT::IGF GENETIC&ESTOTERIC TESTING
Modification chain · 30 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2014-10-22+$735,462= $735,462
- Mod P000022015-06-17+$128,092= $863,554
- Mod P000042015-08-20+$80,000= $943,554
- Mod P000052015-08-20+$20,000= $963,554
- Mod P000072015-09-02+$72,541= $1,036,095
- Mod P000032015-09-29+$105,000= $1,141,095
- Mod P000082015-09-29+$161,000= $1,302,095
- Mod P000062015-10-01+$1,219,000= $2,521,095
- Mod P000112015-11-19+$97,504= $2,618,599
- Mod P000122015-12-18+$436= $2,619,035
- Mod P000132015-12-18+$68,404= $2,687,439
- Mod P000092016-03-10+$29,223= $2,716,662
- Mod P000142016-10-01+$1,833,000= $4,549,662
- Mod P000162017-01-30+$83,646= $4,633,308
- Mod P000152017-04-21+$186,637= $4,819,945
- Mod P000172017-05-24-$14,481= $4,805,465
- Mod P000102017-06-05-$18,953= $4,786,512
- Mod P000182017-07-21-$279= $4,786,233
- Mod P000202017-09-14-$70,552= $4,715,681
- Mod P000192017-10-01+$1,758,400= $6,474,081
- Mod P000212018-05-07-$648,645= $5,825,436
- Mod P000232018-07-23+$0= $5,825,436
- Mod P000222018-10-01+$1,506,000= $7,331,436
- Mod P000242019-07-18+$120,000= $7,451,436
- Mod P000252019-09-10+$0= $7,451,436
- Mod P000262019-10-01+$414,395= $7,865,831
- Mod P000272019-12-26+$414,395= $8,280,226
- Mod P000282020-01-21+$138,243= $8,418,469
- Mod P000292020-04-09-$461,553= $7,956,917
- Mod P000302020-06-20-$330,568= $7,626,349
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2014-10-22 | +$735,462 | $735,462 | IGF::OT::IGF GENETIC&ESTOTERIC TESTING |
| Mod P00002· FUNDING ONLY ACTION | 2015-06-17 | +$128,092 | $863,554 | IGF::OT::IGF GENETIC&ESTOTERIC TESTING PO INCREASE FOR 526C50041 |
| Mod P00004· FUNDING ONLY ACTION | 2015-08-20 | +$80,000 | $943,554 | IGF::OT::IGF GENETIC&ESTOTERIC TESTING PO INCREASE FOR 526C50041 |
| Mod P00005· FUNDING ONLY ACTION | 2015-08-20 | +$20,000 | $963,554 | IGF::OT::IGF GENETIC&ESTOTERIC TESTING PO INCREASE FOR 526C50041 |
| Mod P00007· FUNDING ONLY ACTION | 2015-09-02 | +$72,541 | $1,036,095 | IGF::OT::IGF GENETIC&ESTOTERIC TESTING PO INCREASE FOR 632C50277 |
| Mod P00003· FUNDING ONLY ACTION | 2015-09-29 | +$105,000 | $1,141,095 | IGF::OT::IGF GENETIC&ESTOTERIC TESTING PO INCREASE FOR 526C50041 |
| Mod P00008· FUNDING ONLY ACTION | 2015-09-29 | +$161,000 | $1,302,095 | IGF::OT::IGF GENETIC&ESTOTERIC TESTING PO INCREASE FOR 632C50277 |
| Mod P00006· EXERCISE AN OPTION | 2015-10-01 | +$1,219,000 | $2,521,095 | IGF::OT::IGF GENETIC&ESTOTERIC TESTING PO INCREASE FOR 526C50041 |
| Mod P00011· FUNDING ONLY ACTION | 2015-11-19 | +$97,504 | $2,618,599 | IGF::OT::IGF GENETIC&ESTOTERIC TESTING PO INCREASE FOR 526C50041 |
| Mod P00012· FUNDING ONLY ACTION | 2015-12-18 | +$436 | $2,619,035 | IGF::OT::IGF GENETIC&ESTOTERIC TESTING PO INCREASE FOR 526C50041 |
| Mod P00013· FUNDING ONLY ACTION | 2015-12-18 | +$68,404 | $2,687,439 | IGF::OT::IGF GENETIC&ESTOTERIC TESTING PO INCREASE FOR 526C50041 |
| Mod P00009· FUNDING ONLY ACTION | 2016-03-10 | +$29,223 | $2,716,662 | IGF::OT::IGF GENETIC&ESTOTERIC TESTING PO INCREASE FOR 632C50277 |
| Mod P00014· EXERCISE AN OPTION | 2016-10-01 | +$1,833,000 | $4,549,662 | IGF::OT::IGF GENETIC&ESOTERIC TESTING OPTION YEAR 2 EXERCISE |
| Mod P00016· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2017-01-30 | +$83,646 | $4,633,308 | IGF::OT::IGF GENETIC&ESTOTERIC TESTING PO INCREASE FOR 632C60061 TO COVER 2016 INVOICING. |
| Mod P00015· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2017-04-21 | +$186,637 | $4,819,945 | IGF::OT::IGF GENETIC&ESTOTERIC TESTING PO INCREASE FOR 630C60066 |
| Mod P00017· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2017-05-24 | −$14,481 | $4,805,465 | IGF::OT::IGF GENETIC&ESTOTERIC 12 MONTH TESTING PO DECREASE FOR 62C50231. |
| Mod P00010· CLOSE OUT | 2017-06-05 | −$18,953 | $4,786,512 | IGF::OT::IGF GENETIC&ESTOTERIC TESTING PO DECREASE FOR 526C50041 REDUCING EXCESS FUNDS. |
| Mod P00018· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2017-07-21 | −$279 | $4,786,233 | IGF::OT::IGF GENETIC&ESTOTERIC TESTING PO DECREASE FOR 620C60025. |
| Mod P00020· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2017-09-14 | −$70,552 | $4,715,681 | IGF::OT::IGF GENETIC&ESTOTERIC TESTING PO DECREASE FOR 526C60035. |
| Mod P00019· EXERCISE AN OPTION | 2017-10-01 | +$1,758,400 | $6,474,081 | IGF::OT::IGF GENETIC&ESTOTERIC TESTING PO DECREASE FOR 526C50041 REDUCING EXCESS FUNDS. |
| Mod P00021· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2018-05-07 | −$648,645 | $5,825,436 | IGF::OT::IGF GENETIC&ESTOTERIC TESTING PO DECREASE FOR 526C50041 REDUCING EXCESS FUNDS. |
| Mod P00023· EXERCISE AN OPTION | 2018-07-23 | +$0 | $5,825,436 | IGF::OT::IGF GENETIC&ESTOTERIC TESTING PO DECREASE FOR 526C50041 REDUCING EXCESS FUNDS. |
| Mod P00022· EXERCISE AN OPTION | 2018-10-01 | +$1,506,000 | $7,331,436 | IGF::OT::IGF GENETIC&ESTOTERIC TESTING PO DECREASE FOR 526C50041 REDUCING EXCESS FUNDS. |
| Mod P00024· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2019-07-18 | +$120,000 | $7,451,436 | GENETIC&ESTOTERIC TESTING PO DECREASE FOR 526C50041 REDUCING EXCESS FUNDS. |
| Mod P00025· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2019-09-10 | +$0 | $7,451,436 | GENETIC&ESTOTERIC TESTING |
| Mod P00026· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2019-10-01 | +$414,395 | $7,865,831 | GENETIC&ESTOTERIC TESTING |
| Mod P00027· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2019-12-26 | +$414,395 | $8,280,226 | GENETIC&ESTOTERIC TESTING |
| Mod P00028· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2020-01-21 | +$138,243 | $8,418,469 | GENETIC&ESTOTERIC TESTING |
| Mod P00029· OTHER ADMINISTRATIVE ACTION | 2020-04-09 | −$461,553 | $7,956,917 | GENETIC&ESTOTERIC TESTING |
| Mod P00030· OTHER ADMINISTRATIVE ACTION | 2020-06-20 | −$330,568 | $7,626,349 | GENETIC&ESTOTERIC TESTING |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI NHYWLYK6NBM8)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C25026N0622 | 250-NETWORK CONTRACT OFFICE 10 (36C250) · Q301 · REFERENCE LABORATORY TESTING | $0 | FY2026 |
| 36C25026D0063 | 250-NETWORK CONTRACT OFFICE 10 (36C250) · Q301 · REFERENCE LABORATORY TESTING | $0 | FY2026 |
| 36C25026N0621 | 250-NETWORK CONTRACT OFFICE 10 (36C250) · Q301 · REFERENCE LABORATORY TESTING | $0 | FY2026 |
| 36C25926F0235 | NETWORK CONTRACT OFFICE 19 (36C259) · Q301 · REFERENCE LABORATORY TESTING | $880,000 | FY2026 |
| 36C25026N0626 | 250-NETWORK CONTRACT OFFICE 10 (36C250) · Q301 · REFERENCE LABORATORY TESTING | $0 | FY2026 |
| 36C25026D0066 | 250-NETWORK CONTRACT OFFICE 10 (36C250) · Q301 · REFERENCE LABORATORY TESTING | $0 | FY2026 |
Other recipients under Q301 from 242-NETWORK CONTRACT OFFICE 02 (36C242) (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| 36C24226N0689 | CENTRAL TOX LLC | 242-NETWORK CONTRACT OFFICE 02 (36C242) | $79,995 | FY2026 |
| 36C24226N0607 | QUEST DIAGNOSTICS INCORPORATED | 242-NETWORK CONTRACT OFFICE 02 (36C242) | $675,002 | FY2026 |
| 36C24226N0524 | WYOMING COUNTY COMMUNITY HOSPITAL | 242-NETWORK CONTRACT OFFICE 02 (36C242) | $19,400 | FY2026 |
| 36C24226A0046 | QUEST DIAGNOSTICS INCORPORATED | 242-NETWORK CONTRACT OFFICE 02 (36C242) | $0 | FY2026 |
| 36C24226N0471 | D & D LABORATORY LLC | 242-NETWORK CONTRACT OFFICE 02 (36C242) | $15,519 | FY2026 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA24014F0183_3600_V797P7041A_3600 · retrieved 2026-09-26.